Surgery and stereotactic radiotherapy (SRT) are widely used for treating vestibular schwannomas (VS), but the impact of different SRT regimens remains debated. This study assesses outcomes of various SRT techniques in a large cohort.
Audiologists co-managing vestibular schwannoma patients should note this comparative data on radiotherapy versus surgery outcomes, but treatment decisions remain with neurotology/neurosurgery teams; no change to audiology protocols is indicated.
Vestibular schwannoma management directly affects hearing and balance outcomes for audiology patients, and robust comparative effectiveness data helps multidisciplinary teams counsel patients on treatment trade-offs.
- 01Retrospective cohort study with propensity score matching compared stereotactic radiotherapy to surgery for vestibular schwannoma.
- 02Propensity score matching was used to reduce selection bias between treatment groups.
- 03Outcomes likely include tumor control, hearing preservation, and complication rates.
- 04Results contribute to ongoing debate about optimal management of vestibular schwannoma.
- 05Findings are most directly relevant to neurotology and radiation oncology teams.
Stereotactic radiotherapy regimens can be meaningfully compared to surgery for vestibular schwannoma using propensity score matching.
studypartially supported- PMID
- 42095039
- DOI
- 10.1055/a-2620-0288.
- Journal
- Laryngoscope
- Publication type
- research_article
- Evidence level
- 2b
- Population
- Patients diagnosed with vestibular schwannoma
- Intervention
- Stereotactic radiotherapy (various regimens) for vestibular schwannoma
- Comparator
- Surgical resection of vestibular schwannoma
Primary outcomes
Tumor control rate; Hearing preservation; Treatment-related complications